Evidence map›Paper›PMID 27376471›Full record

ArticleNature immunology2016

CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis.

Danay Cibrian, María Laura Saiz, Hortensia de la Fuente, Raquel Sánchez-Díaz, Olga Moreno-Gonzalo, Inmaculada Jorge, Alessia Ferrarini, Jesús Vázquez, Carmen Punzón, Manuel Fresno and 5 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Nature immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Epidermal and Dermal T Cells Exhibit Distinct Proteomic Signatures.International journal of molecular sciences · 2025
    Article
  9. Article
  10. Review
  11. T cells in cardiac health and disease.The Journal of clinical investigation · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Signaling pathways and targeted therapies for psoriasis.Signal transduction and targeted therapy · 2023
    Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Danay CibrianImmunology Service, Hospital de la Princesa, Universidad Autónoma de Madrid, Instituto Investigación Sanitaria Princesa, Madrid, Spain.
María Laura SaizImmunology Service, Hospital de la Princesa, Universidad Autónoma de Madrid, Instituto Investigación Sanitaria Princesa, Madrid, Spain.
Hortensia de la FuenteImmunology Service, Hospital de la Princesa, Universidad Autónoma de Madrid, Instituto Investigación Sanitaria Princesa, Madrid, Spain.
Raquel Sánchez-DíazDepartment of Vascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
Olga Moreno-GonzaloImmunology Service, Hospital de la Princesa, Universidad Autónoma de Madrid, Instituto Investigación Sanitaria Princesa, Madrid, Spain.
Inmaculada JorgeDepartment of Vascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
Alessia FerrariniDepartment of Vascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
Jesús VázquezDepartment of Vascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
Carmen PunzónDepartment of Molecular Biology, Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, Madrid, Spain.
Manuel FresnoDepartment of Molecular Biology, Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, Madrid, Spain.
Miguel Vicente-ManzanaresImmunology Service, Hospital de la Princesa, Universidad Autónoma de Madrid, Instituto Investigación Sanitaria Princesa, Madrid, Spain.
Esteban DaudénDermatology Service, Hospital de la Princesa, Madrid, Spain.
Pedro M Fernández-SalgueroDepartment of Biochemistry, Molecular Biology and Genetic, Faculty of Sciences, University of Extremadura, Badajoz, Spain.
Pilar MartínDepartment of Vascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.ORCID 0000-0002-2392-1764
Francisco Sánchez-MadridImmunology Service, Hospital de la Princesa, Universidad Autónoma de Madrid, Instituto Investigación Sanitaria Princesa, Madrid, Spain.
Hospital Universitario de La Princesa · ESSpanish National Centre for Cardiovascular Research · ESCentro de Biología Molecular Severo Ochoa · ESUniversidad de Extremadura · ES

Funding

European Research Council 294340
6 · The paper itself

Abstract

The activation marker CD69 is expressed by skin γδ T cells. Here we found that CD69 controlled the aryl hydrocarbon receptor (AhR)-dependent secretion of interleukin 22 (IL-22) by γδ T cells, which contributed to the development of psoriasis induced by IL-23. CD69 associated with the aromatic-amino-acid-transporter complex LAT1-CD98 and regulated its surface expression and uptake of L-tryptophan (L-Trp) and the intracellular quantity of L-Trp-derived activators of AhR. In vivo administration of L-Trp, an inhibitor of AhR or IL-22 abrogated the differences between CD69-deficient mice and wild-type mice in skin inflammation. We also observed LAT1-mediated regulation of AhR activation and IL-22 secretion in circulating Vγ9(+) γδ T cells of psoriatic patients. Thus, CD69 serves as a key mediator of the pathogenesis of psoriasis by controlling LAT1-CD98-mediated metabolic cues.

Indexed as

Amino Acid Transport System y+Amino Acid Transport System y+LAnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensCells, CulturedEndocytosisFusion Regulatory Protein-1Interleukin-22Interleukin-23InterleukinsLectins, C-TypeMiceMice, Inbred C57BLMice, KnockoutAmino Acid Transport System y+Amino Acid Transport System y+LAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensFusion Regulatory Protein-1Interleukin-22Interleukin-23InterleukinsLectins, C-TypeReceptors, Antigen, T-Cell, gamma-deltaReceptors, Aryl HydrocarbonSlc7a7 protein, mouseTryptophan

Identifiers

PMID27376471
PMCPMC5146640
OpenAlexW2475119896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.